- Filed
- Aug 8, 2024 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2024 · Aug 6, 2024 | 24.32M sh |
| Stock Repurchased | Q2 2024 · Jun 30, 2024 | $3.5M |
| Cash And Equivalents | Q2 2024 · Jun 30, 2024 | $60K |
| Cash And Equivalents | Q2 2024 · Dec 31, 2023 | $748K |
| Current Liabilities | Q2 2024 · Jun 30, 2024 | $31.74M |
| Current Liabilities | Q2 2024 · Dec 31, 2023 | $37.33M |
| Total Liabilities | Q2 2024 · Jun 30, 2024 | $51.71M |
| Total Liabilities | Q2 2024 · Dec 31, 2023 | $70.01M |
| Current Assets | Q2 2024 · Jun 30, 2024 | $139.38M |
| Current Assets | Q2 2024 · Dec 31, 2023 | $107.88M |
| Total Assets | Q2 2024 · Jun 30, 2024 | $514.93M |
| Total Assets | Q2 2024 · Dec 31, 2023 | $506.74M |
| Shares Diluted | Q2 2024 · Jun 30, 2023 | 25.1M sh |
| Shares Diluted | Q2 2024 · Jun 30, 2023 | 25.09M sh |
| Capex | Q2 2024 · Jun 30, 2023 | $1.54M |
| Operating Cash Flow | Q2 2024 · Jun 30, 2023 | −$7.46M |
| Stockholders Equity | Q2 2024 · Jun 30, 2023 | $413.19M |
| Stockholders Equity | Q2 2024 · Mar 31, 2023 | $397.87M |
| Stockholders Equity | Q2 2024 · Dec 31, 2022 | $382.1M |
| Eps Diluted | Q2 2024 · Jun 30, 2023 | $0.60 |
| Eps Diluted | Q2 2024 · Jun 30, 2023 | $1.25 |
| Eps Basic | Q2 2024 · Jun 30, 2023 | $0.62 |
| Eps Basic | Q2 2024 · Jun 30, 2023 | $1.28 |
| Sga Expense | Q2 2024 · Jun 30, 2023 | $5.53M |
| Sga Expense | Q2 2024 · Jun 30, 2023 | $10.94M |
| Net Income | Q2 2024 · Jun 30, 2023 | $15.02M |
| Net Income | Q2 2024 · Jun 30, 2023 | $31.3M |
| Net Income | Q2 2024 · Mar 31, 2023 | $16.28M |
| Operating Income | Q2 2024 · Jun 30, 2023 | $17.5M |
| Operating Income | Q2 2024 · Jun 30, 2023 | $35.85M |
| Cost Of Revenue | Q2 2024 · Jun 30, 2023 | $29.71M |
| Cost Of Revenue | Q2 2024 · Jun 30, 2023 | $58.67M |
| Revenue | Q2 2024 · Jun 30, 2023 | $42.32M |
| Revenue | Q2 2024 · Jun 30, 2023 | $85.5M |